COL03 cl.C3	
    			    			
                CSSi005-A            
            
        General
Donor Information
| General Donor Information | |
| Sex | female | 
| Ethnicity | Caucasian | 
| Phenotype and Disease related information (Donor) | |
| Diseases | No disease was diagnosed. | 
| Disease associated phenotypes | no phenotypes | 
| Karyotyping (Donor) | |
| Has the donor karyotype been analysed? | No | 
| External Databases (Donor) | |
| BioSamples | SAMEA994534 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | No | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes | 
| Confirm that consent was obtained by a qualified professional | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | anonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| * Does consent expressly prevent the derivation of pluripotent stem cells? | No | 
| Does consent expressly permit storage of donated embryo/tissue for an unlimited time? | Yes | 
| Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? | Yes | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
| How may genetic information associated with the cell line be accessed? | No information | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | Casa Sollievo della Sofferenza Ethics Commettee | 
| Approval number | 75/CE | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes | 
| Name of accrediting authority involved? | Casa Sollievo della Sofferenza Ethics Commettee | 
| Approval number | 75/CE | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | 
hIPSC Derivation
| General | |
| Source cell type | Any skin fibroblast that is part of some dermis. | 
| Source cell origin | Any portion of the organ that covers that body and consists of a layer of epidermis and a layer of dermis. Synonyms 
 | 
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Episomal | 
| Is reprogramming vector detectable? | Yes | 
| Methods used | 
	RT-PCR	 | 
| Files and images showing reprogramming vector expressed or silenced | |
| Vector map | |
| Vector free reprogramming | |
| Other | |
| Selection criteria for clones | Morphology, immuno-fluorescence analysis and qRT-PCR | 
| Derived under xeno-free conditions | Yes | 
| Derived under GMP? | No | 
| Available as clinical grade? | No | 
Culture Conditions
| Surface coating | Matrigel/Geltrex | 
| Feeder cells | No | 
| Passage method | Mechanically | 
| CO2 Concentration | 5 % | 
| Medium | Other medium: 
			Base medium: NutristemXF 			 Main protein source: Serum concentration: % | 
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No | 
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No | 
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No | 
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| POU5F1 (OCT-4) | Yes |  |  | |||
| TRA 1-60 | Yes |  | 
Morphology pictures
col03 ips colony 3.tif
Phase contrast picture 
Differentiation Potency
| Microbiology / Virus Screening | |
| Mycoplasma | Negative | 
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | Yes | 
| Other Genotyping (Cell Line) | |

Login to share your feedback, experiences or results with the research community.